A. Rose, J. Reisman, Z. Razouki, and A. Ozonoff, Percent Time in Range with Warfarin as a Performance Measure: How Long a Sampling Frame Is Needed?, The Joint Commission Journal on Quality and Patient Safety, vol.41, issue.12, pp.561-569, 2015.
DOI : 10.1016/S1553-7250(15)41073-6

J. Dlott, R. George, X. Huang, M. Odeh, H. Kaufman et al., National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation, Circulation, vol.129, issue.13, pp.1407-1421, 2014.
DOI : 10.1161/CIRCULATIONAHA.113.002601

A. Rose, E. Hylek, A. Ozonoff, A. Ash, J. Reisman et al., Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA), Journal of Thrombosis and Haemostasis, vol.277, issue.10, pp.2182-91, 2010.
DOI : 10.7326/0003-4819-146-12-200706190-00007

W. Baker, D. Cios, S. Sander, and C. Coleman, Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States, Journal of Managed Care Pharmacy, vol.15, issue.3, pp.244-52, 2009.
DOI : 10.18553/jmcp.2009.15.3.244

T. Løkkegaard, T. Pedersen, L. B. Siersma, V. Waldorff, and F. , Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing, Dan Med J. Feb, vol.62, issue.2, 2015.

N. Bernaitis, T. Badrick, A. Davey, S. Anoopkumar-dukie, and . Australia, Quality of warfarin control in atrial fibrillation patients in South East Queensland, Intern Med J, 2016.

D. Fitzmaurice, G. Accetta, S. Haas, G. Kayani, L. Luciardi et al., Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists, British Journal of Haematology, vol.167, issue.4, 2016.
DOI : 10.1001/archinte.167.3.239

S. Djalali, F. Valeri, B. Gerber, D. Meli, and O. Senn, Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials, Clinical and Applied Thrombosis/Hemostasis, vol.62, issue.2, 2016.
DOI : 10.1186/1471-2296-15-159

D. Caldeira, I. Cruz, G. Morgado, B. Stuart, A. Gomes et al., Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study, BMC Research Notes, vol.7, issue.1, p.891, 2009.
DOI : 10.1161/CIRCULATIONAHA.112.142158

A. Gallagher, E. Setakis, J. Plumb, A. Clemens, and T. Van-staa, Risks of troke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. . Thromb Haemost, pp.968-77, 2011.

L. Dallalzadeh, A. Go, Y. Chang, L. Borowsky, M. Fang et al., Stability of High???Quality Warfarin Anticoagulation in a Community???Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, Journal of the American Heart Association, vol.5, issue.7, 2016.
DOI : 10.1161/JAHA.116.003482

I. Lecroart, Traitement anti-coagulant au long cours par anti-vitamines K : Qualité de la prise en charge et suivi biologique en Aquitaine de septembre 2002 à février 2003 - Programme Régional de l'Assurance Maladie, 2002.

L. Bereznicki, S. Jackson, W. Kromdijk, P. Gee, K. Fitzmaurice et al., Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study, International Journal of Pharmacy Practice, vol.179, issue.6 Suppl., pp.84-91, 2014.
DOI : 10.1503/cmaj.080171

R. Nieuwlaat, J. Eikelboom, S. Schulman, H. Van-spall, K. Schulze et al., Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices, Journal of Thrombosis and Thrombolysis, vol.361, issue.4, pp.435-477, 2014.
DOI : 10.1056/NEJMoa0905561

D. Mcnab, J. Mckay, and P. Bowie, A before and after study of warfarin monitoring in a single region as part of the Scottish patient safety programme in primary care, Scottish Medical Journal, vol.35, issue.4, pp.196-201, 2015.
DOI : 10.5172/conu.2010.35.2.234

I. Dimberg, B. Grzymala-lubanski, A. Hägerfelth, M. Rosenqvist, P. Svensson et al., Computerised assistance for warfarin dosage ??? Effects on treatment quality, European Journal of Internal Medicine, vol.23, issue.8, pp.742-746, 2012.
DOI : 10.1016/j.ejim.2012.07.011

T. Khan, F. Kamali, P. Kesteven, P. Avery, and H. Wynne, The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation, British Journal of Haematology, vol.26, issue.4, pp.557-64, 2004.
DOI : 10.1016/S0002-9343(98)00389-1

D. Clarkesmith, H. Pattison, and D. Lane, Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. . Cochrane Database Syst Rev, p.8600, 2013.

D. Clarkesmith, H. Pattison, G. Lip, and D. Lane, Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial, PLoS ONE, vol.102, issue.9, p.74037, 2009.
DOI : 10.1371/journal.pone.0074037.s009

URL : http://doi.org/10.1371/journal.pone.0074037

I. Gouin-thibault, C. Levy, E. Pautas, J. Cambus, L. Drouet et al., Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin, Journal of the American Geriatrics Society, vol.128, issue.(3 Suppl), pp.242-249, 2010.
DOI : 10.1007/s11239-007-0106-9

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1532-5415.2009.02675.x/pdf

A. Cafolla, L. Manisco, E. Baldacci, A. Porcu, M. Campanelli et al., Effectiveness and Safety of Therapy with Vitamin K Antagonists in Italian Patients Aged 80??Years or Older: a Multicentre Retrospective Study Comparing the Zeus Algorithm with the PARMA Algorithm or Manual Therapy, Drugs & Aging, vol.63, issue.3, pp.235-276, 2015.
DOI : 10.1016/j.jacc.2013.07.104

M. Ba?a, Analysis of the successfully implemented Quality Improvement projects concerning cardiovascular diseases in Family Medicine, General Practice in Europe. Krakow, pp.57-59, 2011.

A. Rochfort, V. Kijowska, and K. Dubas, Guidebook on implementation of Quality Improvement in General Practice, pp.40-43, 2012.

P. Bowie, L. Halley, A. Blamey, J. Gillies, and N. Houston, Qualitative evaluation of the Safety and Improvement in Primary Care (SIPC) pilot collaborative in Scotland: perceptions and experiences of participating care teams, BMJ Open, vol.374, issue.1, p.9526, 2016.
DOI : 10.1016/S0140-6736(09)61440-9

A. Georgiou, J. Burns, D. Penn, F. Infante, and M. Harris, Register???Recall Systems: Tools for Chronic Disease Management in General Practice, Health Information Management, vol.325, issue.7370, pp.31-35, 2004.
DOI : 10.1136/bmj.325.7370.925

M. Bishop and M. Streiff, Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients, Journal of Thrombosis and Thrombolysis, vol.16, issue.5, pp.283-290, 2016.
DOI : 10.1111/j.1365-2753.2009.01235.x

E. Mearns, C. White, C. Kohn, J. Hawthorne, J. Song et al., Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression, Thrombosis Journal, vol.12, issue.1, p.14, 2014.
DOI : 10.1186/1477-9560-12-14

M. Das, L. Panter, G. Wynn, R. Taylor, N. Connor et al., Primary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UK, BMJ Open, vol.107, issue.12, p.9267, 2009.
DOI : 10.1160/TH11-11-0784

D. Matchar, Do Anticoagulation Management Services Improve Care? Implications of the Managing Anticoagulation Services Trial, Cardiac Electrophysiology Review, vol.7, issue.4, pp.379-81, 2003.
DOI : 10.1023/B:CEPR.0000023144.60821.d1

F. Rodriguez, C. Hong, Y. Chang, L. Oertel, D. Singer et al., Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic, Journal of the American Heart Association, vol.2, issue.4, p.170
DOI : 10.1161/JAHA.113.000170

M. Cromheecke, M. Levi, L. Colly, B. De-mol, M. Prins et al., Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, The Lancet, vol.356, issue.9224, pp.97-102, 2000.
DOI : 10.1016/S0140-6736(00)02470-3

P. Sharma, G. Scotland, M. Cruickshank, E. Tassie, C. Fraser et al., Funding, Health Technology Assessment, vol.19, issue.48, pp.1-172, 2015.
DOI : 10.3310/hta19480

C. Heneghan, J. Garcia-alamino, E. Spencer, A. Ward, R. Perera et al., Self-monitoring and selfmanagement of oral anticoagulation, Cochrane Database Syst Rev, vol.7, p.3839, 2016.

L. Eger, P. Cambus, J. Boneu, B. Boccalon, and H. , Les cliniques d'anticoagulants?tab=texte Regional Centers of Pharmacovigilance. Iatrogenic medication: estimation of its prevalence in French public hospitals, Sang Thromb Vaiss Therapie, vol.1554, issue.641, pp.901-910, 1999.

. Bien-repérer-la-préférence-de-l-'ip, exprimer les doses en parts de comprimé ou en mg Avec la Coumadine attention +++ si on parle en comprimés

. Prenons-un-exemple, vous venez de recevoir vos résultats d'analyse qui indiquent que votre INR est à 1,2. Qu'est-ce que cela veut dire ?

. Aucun-aliment-n-'est-interdit, Cependant l'apport du régime alimentaire en vitamine K doit être régulier et sans excès ni changement brutal, afin de ne pas perturber l'équilibre de l'INR. Certains aliments peuvent diminuer l'action de l'anticoagulant : cf tableau ci-dessous